Meilleure Health International Industry Group Limited (HK:2327)
:2327
Want to see HK:2327 full AI Analyst Report?
2327 Stock Chart & Stats
HK$0.28
-HK$0.01(-3.39%)
At close: 4:00 PM EST
HK$0.28
-HK$0.01(-3.39%)
Day’s Range― - ―
52-Week RangeHK$0.21 - HK$0.32
Previous CloseN/A
Volume54.00K
Average Volume (3M)3.52M
Market Cap
HK$1.19B
Enterprise ValueHK$1.54B
Total Cash (Recent Filing)HK$20.18M
Total Debt (Recent Filing)HK$380.96M
Price to Earnings (P/E)28.5
Beta0.22
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2%
Share Statistics
EPS (TTM)<0.01
Shares Outstanding4,093,756,600
10 Day Avg. Volume6,054,000
30 Day Avg. Volume3,517,820
Financial Highlights & Ratios
PEG Ratio1.61
Price to Book (P/B)0.87
Price to Sales (P/S)29.64
P/FCF Ratio-21.39
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High Gross MarginsSustained gross margins near 57–62% indicate structural pricing power or a high-margin business mix. This buffer supports long-term margin sustainability, allowing the company to absorb SG&A or investment spending and helps preserve profitability if revenue stabilizes.
Moderate Leverage And Stable Balance SheetDebt-to-equity around 0.19–0.31 and sizable equity suggest a relatively stable balance sheet. That financial flexibility reduces refinancing risk, supports funding for strategic moves, and makes the firm better positioned to endure operating volatility over the medium term.
Steady Positive Returns On EquityConsistent positive ROE in the ~1%–6% range signals the company can generate incremental returns on capital rather than destroy it. While modest, steady ROE reflects baseline operational competence and a foundation for recovery if operating trends improve.
Bears Say
Sharp Revenue DeclineA near-28% revenue drop and consecutive years of contraction undermine scale economics and market position. Persistent top-line erosion reduces ability to leverage fixed costs, threatens long-run competitiveness, and limits resources for product, sales, or market investment.
Operating Profitability DeteriorationA ~-30% EBIT margin in 2025 reveals structural weakness in core operations. Even with high gross margins, negative operating earnings imply cost structure or scale issues that impair sustainable profit generation and heighten dependency on non-operating gains to report net income.
Volatile And Negative Cash GenerationRecent negative operating and free cash flows, and historical volatility, raise funding and earnings-quality risks. Weak cash conversion constrains reinvestment and raises reliance on external financing or asset actions, threatening long-term financial sustainability.
Meilleure Health International Industry Group Limited News
2327 FAQ
What was Meilleure Health International Industry Group Limited’s price range in the past 12 months?
Meilleure Health International Industry Group Limited lowest stock price was HK$0.21 and its highest was HK$0.32 in the past 12 months.
What is Meilleure Health International Industry Group Limited’s market cap?
Meilleure Health International Industry Group Limited’s market cap is HK$1.19B.
When is Meilleure Health International Industry Group Limited’s upcoming earnings report date?
Meilleure Health International Industry Group Limited’s upcoming earnings report date is Aug 27, 2026 which is in 96 days.
How were Meilleure Health International Industry Group Limited’s earnings last quarter?
Meilleure Health International Industry Group Limited released its earnings results on Mar 27, 2026. The company reported HK$0.006 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.006.
Is Meilleure Health International Industry Group Limited overvalued?
According to Wall Street analysts Meilleure Health International Industry Group Limited’s price is currently Overvalued.
Does Meilleure Health International Industry Group Limited pay dividends?
Meilleure Health International Industry Group Limited pays a Notavailable dividend of HK$0.002 which represents an annual dividend yield of 2%. See more information on Meilleure Health International Industry Group Limited dividends here
What is Meilleure Health International Industry Group Limited’s EPS estimate?
Meilleure Health International Industry Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Meilleure Health International Industry Group Limited have?
Meilleure Health International Industry Group Limited has 4,093,756,600 shares outstanding.
What happened to Meilleure Health International Industry Group Limited’s price movement after its last earnings report?
Meilleure Health International Industry Group Limited reported an EPS of HK$0.006 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Meilleure Health International Industry Group Limited?
Currently, no hedge funds are holding shares in HK:2327
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Meilleure Health International Industry Group Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
28.57%
12-Months-Change
Fundamentals
Return on Equity
3.08%
Trailing 12-Months
Asset Growth
8.81%
Trailing 12-Months
Company Description
Meilleure Health International Industry Group Limited
Meilleure Health International Industry Group Limited, an investment holding company, engages in industrial hemp, healthcare-related, trading, agency service, property investment and leasing, and property development businesses in Hong Kong, the People's Republic of China, and internationally. The company is involved in the trading of construction materials; development and sale of residential properties; property investment and leasing activities; and sale of healthcare-related products. It also provides real estate agency services; cannabidiol downstream product application services; health management services, including anti-aging, aesthetic medicine, and other health consulting; and healthcare related product sales agency services. The company was formerly known as U-Home Group Holdings Limited and changed its name to Meilleure Health International Industry Group Limited in March 2017. Meilleure Health International Industry Group Limited is headquartered in Admiralty, Hong Kong.
Meilleure Health International Industry Group Limited (2327) Earnings & Revenues
Technical Analysis
―
Chevalier International Holdings Limited
―
Hong Kong ChaoShang Group Ltd.
―
Aceso Life Science Group Limited
―
Loco Hong Kong Holdings Ltd
―
Options Prices
Currently, No data available
---